The DOI matches its Crossref record; 413 of the 413 references it cites were found in a registry or an index.
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Open accessAbstract
Positron emission tomography (PET) uses radioactive tracers and enables the functional imaging of several metabolic processes, blood flow measurements, regional chemical composition, and/or chemical absorption. Depending on the targeted processes within the living organism, different tracers are used for various medical conditions, such as cancer, particular brain pathologies, cardiac events, and bone lesions, where the most commonly used tracers are radiolabeled with 18F (e.g., [18F]-FDG and NA [18F]). Oxygen-15 isotope is mostly involved in blood flow measurements, whereas a wide array of 11C-based compounds have also been developed for neuronal disorders according to the affected neuroreceptors, prostate cancer, and lung carcinomas. In contrast, the single-photon emission computed tomography (SPECT) technique uses gamma-emitting radioisotopes and can be used to diagnose strokes, seizures, bone illnesses, and infections by gauging the blood flow and radio distribution within tissues and organs. The radioisotopes typically used in SPECT imaging are iodine-123, technetium-99m, xenon-133, thallium-201, and indium-111. This systematic review article aims to clarify and disseminate the available scientific literature focused on PET/SPECT radiotracers and to provide an overview of the conducted research within the past decade, with an additional focus on the novel radiopharmaceuticals developed for medical imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 413
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Smith, R. A., Schöll, M., Londos, E., Ohlsson, T. G., & Hansson, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-23041-x · Cited by 79
Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases
Zhang, D., He, G., & Meng, F. (2021) · Molecules · doi:10.3390/molecules26164907 · Cited by 79
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106
Takano, A., Piehl, F., Hillert, J., Varrone, A., Nag, S., Gulyás, B., Stenkrona, P., Villemagne, V., Rowe, C., Macdonell, R., et al. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-30 · Cited by 78
James, M. L., Belichenko, N. P., Shuhendler, A. J., Höhne, A., Andrews, L., Condon, C., Nguyen, T. V., Reiser, V., Jones, P. A., Trigg, W., et al. (2017) · Theranostics · doi:10.7150/thno.17666 · Cited by 78
van Oordt, C. W. M. D. H., McGeoch, A. T., Bergström, M., McSherry, I. N., Smith, D. A., Cleveland, M., Al‐Azzam, W., Chen, L., Verheul, H. M. W., Hoekstra, O. S., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.214726 · Cited by 78
Mercier, J., Archen, L., Bollu, V., Carré, S., Evrard, Y., Jnoff, E., Kenda, B., Lallemand, B., Michel, P., Montel, F., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300482 · Cited by 77
18F-ASEM, a Radiolabeled Antagonist for Imaging the α7-Nicotinic Acetylcholine Receptor with PET
Horti, A. G., Gao, Y., Kuwabara, H., Wang, Y., Abazyan, S., Yasuda, R. P., Tran, T. P., Xiao, Y., Sahibzada, N., Holt, D. P., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132068 · Cited by 77
Ulaner, G. A., Carrasquillo, J. A., Riedl, C. C., Yeh, R., Hatzoglou, V., Ross, D. S., Jhaveri, K. L., Chandarlapaty, S., Hyman, D. M., Zeglis, B. M., et al. (2020) · Radiology · doi:10.1148/radiol.2020192828 · Cited by 77
68Ga-NOTA-Aca-BBN(7–14) PET/CT in Healthy Volunteers and Glioma Patients
Zhang, J., Li, D., Lang, L., Zhu, Z., Wang, L., Wu, P., Niu, G., Li, F., & Chen, X. S. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.165316 · Cited by 76
Lawal, I. O., Ankrah, A. O., Mokgoro, N. P., Vorster, M., Maes, A., & Sathekge, M. M. (2017) · The Prostate · doi:10.1002/pros.23379 · Cited by 74
Sah, B.-R., Burger, I. A., Schibli, R., Friebe, M., Dinkelborg, L. M., Graham, K., Borkowski, S., Bacher-Stier, C., Valencia, R., Srinivasan, A., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147116 · Cited by 73
Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow
Renaud, J. M., Yip, K., Guimond, J. V., Trottier, M., Pîbarot, P., Turcotte, É. E., Maguire, C., Lalonde, L. D., Gulenchyn, K. Y., Farncombe, T. H., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.174565 · Cited by 73
Finnema, S. J., Stepanov, V., Ettrup, A., Nakao, R., Amini, N., Svedberg, M., Lehmann, C., Hansen, M., Knudsen, G. M., & Halldin, C. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.035 · Cited by 72
Bensch, F., Lamberts, L. E., Smeenk, M. M., Jorritsma‐Smit, A., Hooge, M. N. L., van Scheltinga, A. G. T. T., de Jong, J. R., Gietema, J. A., Schröder, C. P., Thomas, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0311 · Cited by 72
PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
Auletta, S., Varani, M., Horvat, R., Galli, F., Signore, A., & Hess, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020197 · Cited by 72
Ebenhan, T., Sathekge, M. M., Lengana, T., Koole, M. J. B., Gheysens, O. S., Govender, T., & Zeevaart, J. R. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.200048 · Cited by 71
Radiopharmaceutical tracers for cardiac imaging
Manabe, O., Kikuchi, T., Scholte, A. J. H. A., Mahdiui, M. E., Nishii, R., Zhang, M., Suzuki, E., & Yoshinaga, K. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1131-5 · Cited by 71
Kim, S., Pak, K., & Kim, K. (2018) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2018.10.013 · Cited by 71
New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
Sogbein, O. O., Pelletier‐Galarneau, M., Schindler, T. H., Wei, L., Wells, R. G., & Ruddy, T. D. (2014) · BioMed Research International · doi:10.1155/2014/942960 · Cited by 70
Designing the Magic Bullet? The Advancement of Immuno-PET into Clinical Use
Wright, B. D., & Lapi, S. E. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.126086 · Cited by 70
Integrin αvβ3 Imaging of Radioactive Iodine–Refractory Thyroid Cancer Using 99mTc-3PRGD2
Zhao, D., Jin, X., Li, F., Liang, J., & Lin, Y. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.107821 · Cited by 70
Su, Z., Herholz, K., Gerhard, A., Roncaroli, F., du Plessis, D., Jackson, A., Turkheimer, F., & Hinz, R. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2447-2 · Cited by 70
Evazalipour, M., D’Huyvetter, M., Tehrani, B. S., Abolhassani, M., Omidfar, K., Abdoli, S., Arezumand, R., Morovvati, H., Lahoutte, T., Muyldermans, S., et al. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1558 · Cited by 70
18F-FDG PET/CT for invasive fungal infection in immunocompromised patients
Leroy‐Freschini, B., Treglia, G., Argemi, X., Bund, C., Kessler, R., Herbrecht, R., & Impériale, A. (2018) · QJM · doi:10.1093/qjmed/hcy128 · Cited by 70
Lohrmann, C., O'Reilly, E. M., O’Donoghue, J. A., Pandit-Taskar, N. D., Carrasquillo, J. A., Lyashchenko, S. K., Ruan, S., Teng, R. S. Y., Scholz, W. W., Maffuid, P. W., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3667 · Cited by 70
Recent Advances in Synthetic Methods for Radioiodination
Dubost⧫, E., McErlain, H., Babin, V., Sutherland, A. J., & Cailly, T. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c00644 · Cited by 70
Probes for Non-invasive Matrix Metalloproteinase-targeted Imaging with PET and SPECT
Matusiak, N., van Waarde, A., Bischoff, R., Oltenfreiter, R., van Wiele, C., Dierckx, R. A. J. O., & Elsinga, P. H. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319250011 · Cited by 69
Douglas, A. P., Thursky, K., Worth, L. J., Drummond, E. G. P., Hogg, A., Hicks, R. J., & Slavin, M. A. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4062-8 · Cited by 69
[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery
Li, X., Yu, W., Wollenweber, T., Lu, X., Wei, Y., Beitzke, D., Wadsak, W., Kropf, S., Wester, H. J., Haug, A. R., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04322-7 · Cited by 68
Wong, D. F., Kuwabara, H., Horti, A. G., Roberts, J., Nandi, A., Cascella, N. G., Brašić, J. R., Weerts, E. M., Kitzmiller, K., Phan, J.-A., et al. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy021 · Cited by 68
Harada, N., Nishiyama, S., Kanazawa, M., & Tsukada, H. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3056 · Cited by 67
Influence of TSPO Genotype on 11C-PBR28 Standardized Uptake Values
Yoder, K. K., Nho, K. T., Risacher, S. L., Kim, S., Shen, L., & Saykin, A. J. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.118885 · Cited by 67
Lohith, T. G., Zoghbi, S. S., Morse, C. L., Araneta, M. F., Barth, V., Goebl, N. A., Tauscher, J. T., Pike, V. W., Innis, R. B., & Fujita, M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.097162 · Cited by 67
Advances in clinical molecular imaging instrumentation
Hutton, B. F., Erlandsson, K., & Thielemans, K. (2018) · Clinical and Translational Imaging · doi:10.1007/s40336-018-0264-0 · Cited by 67
Tsukada, H., Nishiyama, S., Fukumoto, D., Kanazawa, M., & Harada, N. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.125328 · Cited by 65
Carrasquillo, J. A., Fine, B. M., Pandit-Taskar, N. D., Larson, S. M., Fleming, S. E., Fox, J. J., Cheal, S. M., O’Donoghue, J. A., Ruan, S., Ragupathi, G., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.222844 · Cited by 65
Boramino acid as a marker for amino acid transporters
Liu, Z., Chen, H., Chen, K., Shao, Y., Kiesewetter, D. O., Niu, G., & Chen, X. S. (2015) · Science Advances · doi:10.1126/sciadv.1500694 · Cited by 64
Gao, Y. N., Kellar, K. J., Yasuda, R. P., Tran, T. P., Xiao, Y., Dannals, R. F., & Horti, A. G. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401184f · Cited by 64
In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317
Betthauser, T. J., Lao, P. J., Murali, D., Barnhart, T. E., Furumoto, S., Okamura, N., Stone, C. K., Johnson, S. C., & Christian, B. T. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.182980 · Cited by 64
Yoshii, Y., Furukawa, T., Kiyono, Y., Watanabe, R., Mori, T., Yoshii, H., Asai, T., Okazawa, H., Welch, M. J., & Fujibayashi, Y. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.08.009 · Cited by 63
Everolimus Reduces 89Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
van Asselt, S. J., Oosting, S. F., Brouwers, A. H., Bongaerts, A. H. H., de Jong, J. R., Hooge, M. N. L., Munnink, T. H. O., Fiebrich, H., Sluiter, W. J., Links, T. P., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129056 · Cited by 63
Barret, O., Thomae, D., Tavares, A., Alagille, D., Papin, C., Waterhouse, R. N., McCarthy, T. J., Jennings, D. L., MAREK, K. L., Russell, D., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.122895 · Cited by 63
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy.
Smith, R., Schöll, M., Honer, M., Nilsson, C. F., Englund, E., & Hansson, O. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1650-1 · Cited by 62
TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?
Largeau, B., Dupont, A.-C., Guilloteau, D., Ribeiro, M. J., & Arlicot, N. (2017) · Contrast Media & Molecular Imaging · doi:10.1155/2017/6592139 · Cited by 62
New Radionuclides and Technological Advances in SPECT and PET Scanners
van der Meulen, N. P., Strobel, K., & Lima, T. V. M. (2021) · Cancers · doi:10.3390/cancers13246183 · Cited by 62
Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology
Jonasson, M., Wall, A. E., Chiotis, K., Saint‐Aubert, L., Wilking, H., Sprycha, M., Borg, B., Thibblin, A., Eriksson, J., Sørensen, J., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158519 · Cited by 61
Taddei, C., & Pike, V. W. (2019) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-019-0073-4 · Cited by 60
Radiosynthesis and Characterization of 11C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor
Parker, C. A., Gunn, R. N., Rabiner, E. A., Slifstein, M., Comley, R. A., Salinas, C. A., Johnson, C. N., Jakobsen, S., Houle, S., Laruelle, M. A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093419 · Cited by 59
Noninvasive Imaging of CCR2+ Cells in Ischemia-Reperfusion Injury After Lung Transplantation
Liu, Y., Li, W., Luehmann, H. P., Zhao, Y., Detering, L., Sultan, D. H., Hsiao, H.-M., Krupnick, A. S., Gelman, A. E., Combadière, C., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13907 · Cited by 59
Mercier, J., Provins, L., & Valade, A. (2017) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2017.11.003 · Cited by 59
Shrestha, S., Kim, M.-J., Eldridge, M. A. G., Lehmann, M. L., Frankland, M. P., Liow, J., Yu, Z., Cortes-Salva, M. Y., Telu, S., Henter, I. D., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01804-6 · Cited by 59
Knowles, S. M., Zettlitz, K. A., Tavaré, R., Rochefort, M. M., Salazar, F. B., Stout, D. B., Yazaki, P. J., Reiter, R. E., & Wu, A. M. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120873 · Cited by 58
The role of new PET tracers for lung cancer
Szyszko, T. A., Yip, C., Szlosarek, P. W., Goh, V., & Cook, G. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.01.010 · Cited by 58
PET-based Imaging of Chemokine Receptor 2 in Experimental and Disease-related Lung Inflammation
Liu, Y., Gunsten, S. P., Sultan, D. H., Luehmann, H. P., Zhao, Y., Blackwell, T. S., Bollermann-Nowlis, Z., Pan, J., Byers, D. E., Atkinson, J. J., et al. (2017) · Radiology · doi:10.1148/radiol.2016161409 · Cited by 58
Xu, X., Zhang, J., Hu, S., He, S., Bao, X., Ma, G., Luo, J., Cheng, J., & Zhang, Y. (2017) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2017.01.010 · Cited by 58
Sospedra, M. (2018) · Current Opinion in Neurology · doi:10.1097/wco.000000000000563 · Cited by 58
Moek, K. L., Waaijer, S. J. H., Kok, I. C., Suurs, F. V., Brouwers, A. H., van Oordt, C. W. M. D. H., Wind, T. T., Gietema, J. A., Schröder, C. P., Mahesh, S. V. K., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2918 · Cited by 58
Bahce, I., Huisman, M. C., Verwer, E. E., Ooijevaar, R. E., Boutkourt, F., Vugts, D. J., van Dongen, G. A. M. S., Boellaard, R., & Smit, E. F. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0035-5 · Cited by 57
In Vivo Mapping of Vascular Inflammation Using the Translocator Protein Tracer 18 F-FEDAA1106
Cuhlmann, S., Gsell, W., der Heiden, K. V., Habib, J., Tremoleda, J. L., Khalil, M. M., Turkheimer, F., Meens, M. J. P. M. T., Kwak, B. R., Bird, J., et al. (2014) · Molecular Imaging · doi:10.2310/7290.2014.00014 · Cited by 57
Rinne, P., Hellberg, S., Kiugel, M., Virta, J., Li, X., Käkelä, M., Helariutta, K., Luoto, P., Liljenbäck, H., Hakovirta, H. H., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0873-1 · Cited by 57
Kinetic Analysis and Quantification of [11C]Martinostat for in Vivo HDAC Imaging of the Brain
Wey, H., Wang, C., Schroeder, F. A., Logan, J., Price, J. C., & Hooker, J. M. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00066 · Cited by 56
Zhang, X. M., Zhang, H. H., McLeroth, P., Berkowitz, R. D., Mont, M. A., Stabin, M. G., Siegel, B. A., Alavi, A. A., Barnett, T. M., Gelb, J., et al. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.01.004 · Cited by 56
Hillmer, A. T., Li, S., Zheng, M., Scheunemann, M., Lin, S.-F., Nabulsi, N., Holden, D., Pracitto, R., Labaree, D. C., Ropchan, J. R., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3621-8 · Cited by 56
Radiolabeled somatostatin analogs-a continuously evolving class of radiopharmaceuticals.
Fani, M., Mansi, R., Nicolas, G. P., & Wild, D. (2022) · Cancers · doi:10.3390/cancers14051172 · Cited by 56
Novel PET Imaging of Atherosclerosis with 68Ga-Labeled NOTA-Neomannosylated Human Serum Albumin
Kim, E. J., Kim, S., Seo, H. S., Lee, Y.-J., Eo, J. S., Jeong, J. M., Lee, B., Kim, J. Y., Park, Y. M., & Jeong, M. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.172650 · Cited by 54
Butsch, V., Börgel, F., Galla, F., Schwegmann, K., Hermann, S., Schäfers, M. A., Riemann, B., Wünsch, B., & Wagner, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00200 · Cited by 54
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology
Rangger, C. A., & Haubner, R. (2020) · Pharmaceuticals · doi:10.3390/ph13020022 · Cited by 54
Kumar, K., & Ghosh, A. K. (2021) · Molecules · doi:10.3390/molecules26020414 · Cited by 54
Characterization in Humans of 18F-MNI-444, a PET Radiotracer for Brain Adenosine 2A Receptors
Barret, O., Hannestad, J. O., Vala, C., Alagille, D., Tavares, A., Laruelle, M. A., Jennings, D. L., MAREK, K. L., Russell, D., Seibyl, J. P., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.152546 · Cited by 53
Postnov, A. A., Schmidt, M. E., Pemberton, D. J., Hoon, J. N. J. M. D., Hecken, A. V., van den Boer, M., Zannikos, P., van der Ark, P. D., Palmer, J. A., Rassnick, S., et al. (2018) · Clinical and Translational Science · doi:10.1111/cts.12548 · Cited by 53
Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis
Contentti, E. C., & Correale, J. D. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1822817 · Cited by 53
Tyacke, R. J., Fisher, A. S., Robinson, E. S. J., Grundt, P., Turner, E. M., Husbands, S. M., Hudson, A. L., Parker, C. A., & Nutt, D. (2012) · Synapse · doi:10.1002/syn.21541 · Cited by 52
Tsukada, H., Nishiyama, S., Ohba, H., Kanazawa, M., Kakiuchi, T., & Harada, N. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2821-8 · Cited by 52
Li, J., Zheng, H., Fodah, R. A., Warawa, J. M., & Ng, C. K. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195420 · Cited by 52
Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys
Kim, M.-J., Shrestha, S., Cortes, M., Singh, P., Morse, C. L., Liow, J., Gladding, R. L., Brouwer, C., Henry, K. A., Gallagher, E. P., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.211144 · Cited by 52
Discriminatory ability of next-generation tau PET tracers for Alzheimer’s disease
Yap, S. Y., Frias, B., Wren, M. C., Schöll, M., Fox, N. C., Årstad, E., Lashley, T., & Sander, K. (2021) · Brain · doi:10.1093/brain/awab120 · Cited by 52
Zettlitz, K. A., Tavaré, R., Knowles, S. M., Steward, K. K., Timmerman, J. M., & Wu, A. M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0855 · Cited by 51
Bernard‐Gauthier, V., Mossine, A. V., Mahringer, A., Aliaga, A., Bailey, J. J., Shao, X., Stauff, J., Arteaga, J., Sherman, P. S., Grand’Maison, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01607 · Cited by 51
89Zr-PET imaging in humans: a systematic review
Feo, M. S. D., Pontico, M., Frantellizzi, V., Corica, F., Cristofaro, F. D., & Vincentis, G. D. (2021) · Clinical and Translational Imaging · doi:10.1007/s40336-021-00462-9 · Cited by 51
Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Sites in Rhesus Brain
Parker, C. A., Nabulsi, N., Holden, D., Lin, S.-F., Cass, T., Labaree, D. C., Kealey, S., Gee, A. D., Husbands, S. M., Quelch, D. R., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131854 · Cited by 51
Sundaram, G. S. M., Dhavale, D. D., Prior, J. L., Yan, P., Cirrito, J. R., Rath, N. P., Laforest, R. A., Cairns, N. J., Lee, J., Kotzbauer, P. T., et al. (2016) · Scientific Reports · doi:10.1038/srep35636 · Cited by 50
Bruijnen, S. T. G., Tsang-A-Sjoe, M. W. P., Raterman, H. G., Ramwadhdoebé, T. H., Vugts, D. J., van Dongen, G. A. M. S., Huisman, M. C., Hoekstra, O. S., Tak, P. P., Voskuyl, A. E., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1166-z · Cited by 50
Lopez‐Picon, F. R., Snellman, A., Eskola, O., Helin, S., Solin, O. H., Haaparanta‐Solin, M., & Rinne, J. O. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.197608 · Cited by 49
Kim, M.-J., Lee, J., Anaya, F. J., Hong, J. S., Miller, W., Telu, S., Singh, P., Cortes, M., Henry, K. A., Tye, G. L., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04855-2 · Cited by 49
PET/CT Imaging for Personalized Management of Infectious Diseases
Pijl, J. P., Kwee, T. C., Slart, R. H. J. A., & Glaudemans, A. W. J. M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020133 · Cited by 49
Hellberg, S., Silvola, J. M. U., Kiugel, M., Liljenbäck, H., Savisto, N., Li, X., Thiele, A., Lehmann, L. E., Heinrich, T. K., Vollmer, S., et al. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0527-y · Cited by 48
van Waarde, A., Dierckx, R., Zhou, X., Khanapur, S., Tsukada, H., Ishiwata, K., Luurtsema, G., de Vries, E. F. J., & Elsinga, P. H. (2017) · Medicinal Research Reviews · doi:10.1002/med.21432 · Cited by 47
Li, W., Luehmann, H. P., Hsiao, H.-M., Tanaka, S., Higashikubo, R., Gauthier, J. M., Sultan, D. H., Lavine, K. J., Brody, S. L., Gelman, A. E., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310517 · Cited by 47
Chaney, A. M., Cropper, H. C., Johnson, E. M., Lechtenberg, K. J., Peterson, T. C., Stevens, M. Y., Buckwalter, M., & James, M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.209155 · Cited by 47
Driessen, R. S., Danad, I., Stuijfzand, W. J., Schumacher, S. P., Knuuti, J. M., Mäki, M. T., Lammertsma, A. A., van Rossum, A. C., van Royen, N., Raijmakers, P. G. H. M., et al. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007417 · Cited by 47
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
Arneson, L. C., Carroll, K., & Ruderman, E. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s288550 · Cited by 47
Sone, D., Imabayashi, E., Maikusa, N., Okamura, N., Furumoto, S., Kudo, Y., Ogawa, M., Takano, H., Yokoi, Y., Sakata, M., et al. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.07.001 · Cited by 46
Simmons, D. A., James, M. L., Belichenko, N. P., Semaan, S., Condon, C., Kuan, J., Shuhendler, A. J., Miao, Z., Chin, F. T., & Longo, F. M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy202 · Cited by 46
The validity of 18F-GE180 as a TSPO imaging agent
Zanotti‐Fregonara, P., Veronese, M., Pascual, B., Rostomily, R., Turkheimer, F., & Masdeu, J. C. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-4268-4 · Cited by 46
Seo, Y., Gustafson, W. C., Dannoon, S. F., Nekritz, E. A., Lee, C.-L., Murphy, S. T., VanBrocklin, H. F., Hernandez‐Pampaloni, M., Haas-Kogan, D. A., Weiss, W. A., et al. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0552-4 · Cited by 45
PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in the Brains of MPTP-Treated Monkeys
Tsukada, H., Kanazawa, M., Ohba, H., Nishiyama, S., Harada, N., & Kakiuchi, T. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.169615 · Cited by 45
Paquette, M., Lavallée, É., Phoenix, S., Ouellet, R., Senta, H., van Lier, J. E., Guérin, B., Lecomte, R., & Turcotte, É. E. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.194654 · Cited by 45
Zettlitz, K. A., Tsai, W. K., Knowles, S. M., Kobayashi, N., Donahue, T. R., Reiter, R. E., & Wu, A. M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.207332 · Cited by 45
Imaging Protein Misfolding in the Brain Using β-Sheet Ligands
Harada, R., Okamura, N., Furumoto, S., & Yanai, K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00585 · Cited by 45
Programmed Cell Death-1/Ligand-1 PET Imaging
Verhoeff, S. R., van den Heuvel, M. M., van Herpen, C. M. L., Piet, B., Aarntzen, E. H. J. G., & Heskamp, S. (2019) · PET Clinics · doi:10.1016/j.cpet.2019.08.008 · Cited by 45
Kim, D.-Y., Kim, H.-S., Le, U. N., Jiang, S. N., Kim, H.-J., Lee, K.-C., Woo, S., Chung, J., Kim, H.-S., Bom, H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.102657 · Cited by 44
Mojtahedi, A., Alavi, A. A., Thamake, S. I., Amerinia, R., Ranganathan, D., Tworowska, I., & Delpassand, E. S. (2015) · Europe PMC (PubMed Central) · Cited by 43
Peptide Receptor–Targeted Radionuclide Therapy Alters Inflammation in Atherosclerotic Plaques
Schatka, I., Wollenweber, T., Haense, C., Brunz, F., Gratz, K. F., & Bengel, F. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1624 · Cited by 43
Maya, Y., Okumura, Y., Kobayashi, R., Onishi, T., Shoyama, Y., Barret, O., Alagille, D., Jennings, D. L., MAREK, K. L., Seibyl, J. P., et al. (2015) · Brain · doi:10.1093/brain/awv305 · Cited by 43
Chen, C.-J., Bando, K., Ashino, H., Taguchi, K., Shiraishi, H., Shima, K., Fujimoto, O., Kitamura, C., Matsushima, S., Uchida, K., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.146944 · Cited by 43
Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody
Tsai, W. K., Zettlitz, K. A., Tavaré, R., Kobayashi, N., Reiter, R. E., & Wu, A. M. (2018) · Theranostics · doi:10.7150/thno.27679 · Cited by 43
Bordonné, M., Chawki, M. B., Marie, P., Zaragori, T., Roch, V., Grignon, R., Imbert, L., & Verger, A. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-00334-7 · Cited by 43
Gialleonardo, V. D., Signore, A., Willemsen, A. T. M., Sijbesma, J. W. A., Dierckx, R., & de Vries, E. F. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2176-y · Cited by 42
van Brummelen, E. M. J., Huisman, M. C., der Veen, B. J. D. W., Nayak, T. K., Stokkel, M. P. M., Mulder, E. R., Hoekstra, O. S., Vugts, D. J., van Dongen, G. A. M. S., Verheul, H. M. W., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25343 · Cited by 42
Radiation dose in nuclear medicine: the hybrid imaging
Salvatori, M., Rizzo, A., Rovera, G., et al. (2019) · La radiologia medica · doi:10.1007/s11547-019-00989-y · Cited by 42
Tsukada, H., Ohba, H., Kanazawa, M., Kakiuchi, T., & Harada, N. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2628-z · Cited by 41
Bier, G., Hoffmann, V., Kloth, C., Othman, M. I. A., Eigentler, T., Garbe, C., la Fougère, C., Pfannenberg, C., Nikolaou, K., & Klumpp, B. D. (2016) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.01.012 · Cited by 41
Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT
Lopci, E., Grassi, I., Rubello, D., Colletti, P. M., Cambioli, S., Gamboni, A., Salvi, F., Cicoria, G., Lodi, F., Dazzi, C., et al. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001017 · Cited by 40
Houghton, J. L., Abdel-Atti, D., Scholz, W. W., & Lewis, J. S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01130 · Cited by 40
O’Donoghue, J. A., Danila, D. C., Pandit-Taskar, N. D., Beylergil, V., Cheal, S. M., Fleming, S. E., Fox, J. J., Ruan, S., ZANZONICO, P. B., Ragupathi, G., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00326 · Cited by 40
Meier, S. R., Sehlin, D., Roshanbin, S., Falk, V. L., Saito, T., Saido, T. C., Neumann, U., Rokka, J., Eriksson, J., & Syvänen, S. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262083 · Cited by 40
Knowles, S. M., Tavaré, R., Zettlitz, K. A., Rochefort, M. M., Salazar, F. B., Jiang, Z. K., Reiter, R. E., & Wu, A. M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1452 · Cited by 38
Adenosine 2A Receptor Occupancy by Tozadenant and Preladenant in Rhesus Monkeys
Barret, O., Hannestad, J. O., Alagille, D., Vala, C., Tavares, A., Papin, C., Morley, T. J., Fowles, K., Lee, H. S., Seibyl, J. P., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.142067 · Cited by 38
123 I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies
Mazère, J., Lamare, F., Michèle Allard, A., Fernandez, P., & Mayo, W. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.176180 · Cited by 38
Varasteh, Z., Hyafil, F., Anizan, N., Diallo, D., Aid‐Launais, R., Mohanta, S., Li, Y.-F., Braeuer, M., Steiger, K., Vigne, J., et al. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0287-y · Cited by 38
Tumor targeting with 99m Tc radiolabeled peptides: Clinical application and recent development
Rezazadeh, F., & Sadeghzadeh, N. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13413 · Cited by 38
Horti, A. G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.030 · Cited by 37
11C-Acetate PET Imaging in Patients with Multiple Sclerosis
Takata, K., Kato, H., Shimosegawa, E., Okuno, T., Koda, T., Sugimoto, T., Mochizuki, H., Hatazawa, J., & Nakatsuji, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111598 · Cited by 37
PET Imaging of Chemokine Receptors in Vascular Injury–Accelerated Atherosclerosis
Liu, Y., Pierce, R. A., Luehmann, H. P., Sharp, T. L., & Welch, M. J. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114777 · Cited by 37
Sridharan, S., Raffel, J., Nandoskar, A., Record, C. J., Brooks, D. J., Owen, D. R., Sharp, D., Muraro, P. A., Gunn, R. N., & Nicholas, R. S. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01323-8 · Cited by 37
Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
Liu, P., Hamill, T. G., Chioda, M. D., Chobanian, H. R., Fung, S., Guo, Y., Chang, L. L., Bakshi, R. K., Hong, Q., Dellureficio, J., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000996 · Cited by 36
Clinical use of 11C-methionine and 18F-FDG-PET for germinoma in central nervous system
Okochi, Y., Nihashi, T., Fujii, M., Kato, K., Okada, Y., Ando, Y., Maesawa, S., Takebayashi, S., Wakabayashi, T., & Naganawa, S. (2013) · Annals of Nuclear Medicine · doi:10.1007/s12149-013-0787-4 · Cited by 36
Metabotropic glutamate receptor 5 – a promising target in drug development and neuroimaging
Pillai, R. L. I., & Tipre, D. N. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3301-5 · Cited by 36
Tremoleda, J. L., Thau‐Zuchman, O., Davies, M., Foster, J., Khan, I., Vadivelu, K. C., Yip, P. K., Sosabowski, J. K., Trigg, W., & Michael-Titus, A. T. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3391-8 · Cited by 36
Hellberg, S., Silvola, J. M. U., Kiugel, M., Liljenbäck, H., Metsälä, O., Viljanen, T., Metso, J., Jauhiainen, M., Saukko, P. J., Nuutila, P., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0340-6 · Cited by 35
Butler, T., Harvey, P., Deshpande, A., Tanzi, E. B., Li, Y., Tsui, W., Silver, C., Fischer, E., Wang, X., Chen, J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.014 · Cited by 35
Young, R. J., França, P. D. D. S., Pirovano, G., Piotrowski, A. F., Nicklin, P. J., Riedl, C. C., Schwartz, J., Bale, T., Donabedian, P. L., Kossatz, S., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa119 · Cited by 35
Sagnou, M., Mavroidi, B., Shegani, A., Paravatou‐Petsotas, M., Raptopoulou, C. P., Psycharis, V., Pirmettis, I. C., Papadopoulos, M. S., & Pelecanou, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01949 · Cited by 34
Lu, S., Haskali, M. B., Ruley, K. M., Dreyfus, N., DuBois, S. L., Paul, S., Liow, J., Morse, C. L., Kowalski, A., Gladding, R. L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aau2939 · Cited by 34
Radiotracers for SPECT imaging: current scenario and future prospects
Adak, S., Bhalla, R., Raj, K. K. V., Mandal, S., Pickett, R. D., & Luthra, S. K. (2012) · Radiochimica Acta · doi:10.1524/ract.2011.1891 · Cited by 33
Non-FDG imaging of atherosclerosis: Will imaging of MMPs assess plaque vulnerability?
Hermann, S., Staršíchová, A., Waschkau, B., Kuhlmann, M. T., Wenning, C., Schober, O., & Schäfers, M. A. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9553-6 · Cited by 33
Evaluation of 124I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized mice
Huang, H., Zhu, H., Xie, Q., Tian, X., Yang, X., Feng, F., Jiang, Q., Sheng, X., & Yang, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.004 · Cited by 33
Preclinical Evaluation of RYM1, a Matrix Metalloproteinase–Targeted Tracer for Imaging Aneurysm
Toczek, J., Ye, Y., Gona, K. B., Kim, H.-Y., Han, J., Razavian, M., Golestani, R., Zhang, J., WU, T. L., Jung, J., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.188656 · Cited by 32
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives
Ramusino, M. C., Perini, G., Altomare, D., Barbarino, P., Weidner, W. S., Porro, G. S., Barkhof, F., Rabinovici, G. D., van der Flier, W. M., Frisoni, G. B., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05187-x · Cited by 32
Yan, X., Telu, S., Dick, R. M., Liow, J., Zanotti‐Fregonara, P., Morse, C. L., Manly, L. S., Gladding, R. L., Shrestha, S., Lerchner, W., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211007949 · Cited by 32
Hatori, A., Yui, J., Xie, L., Yamasaki, T., Kumata, K., Fujinaga, M., Wakizaka, H., Ogawa, M., Nengaki, N., Kawamura, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086625 · Cited by 31
Kaster, T. S., Dwivedi, G., Susser, L., Renaud, J. M., Beanlands, R. S., Chow, B. J. W., & deKemp, R. A. (2014) · Journal of Nuclear Cardiology · doi:10.1007/s12350-014-0026-y · Cited by 31
Golestani, R., Zeebregts, C. J., van Scheltinga, A. G. T. T., Hooge, M. N. L., van Dam, G. M., Glaudemans, A. W. J. M., Dierckx, R., Tio, R. A., Suurmeijer, A. J. H., Boersma, H. H., et al. (2013) · Molecular Imaging · doi:10.2310/7290.2012.00034 · Cited by 31
Advanced Tracers in PET Imaging of Cardiovascular Disease
Li, Y., Zhang, W., Wu, H., & Liu, G. (2014) · BioMed Research International · doi:10.1155/2014/504532 · Cited by 30
Effects of erlotinib therapy on [11C]erlotinib uptake in EGFR mutated, advanced NSCLC
Bahce, I., Yaqub, M. M., Errami, H., Schuit, R. C., Schober, P. R., Thunnissen, E., Windhorst, A. D., Lammertsma, A. A., Smit, E. F., & Hendrikse, N. H. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0169-8 · Cited by 30
The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases
Dupont, A.-C., Largeau, B., Guilloteau, D., Ribeiro, M. J., & Arlicot, N. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/7043578 · Cited by 30
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
Ni, R., & Nitsch, R. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.751897 · Cited by 30
Strebl, M. G., Wang, C., Schroeder, F. A., Placzek, M. S., Wey, H., de Bittner, G. C. V., Neelamegam, R., & Hooker, J. M. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00297 · Cited by 29
Fathala, A. L., Aboulkheir, M., Shoukri, M., & Alsergani, H. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.10.12 · Cited by 29
G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
van der Vorst, E. P. C., Peters, L. J. F., Müller, M., Gencer, S., Yan, Y., Weber, C., & Döring, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00531 · Cited by 29
Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Cybulska, K. A., Perk, L. R., Booij, J., Laverman, P., & Rijpkema, M. (2020) · Molecules · doi:10.3390/molecules25030482 · Cited by 29
Koole, M. J. B., Lohith, T. G., Valentine, J. L., Bennacef, I., Declercq, R., Reynders, T., Riffel, K. A., Celen, S., Serdons, K., Bormans, G. M., et al. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01367-w · Cited by 28
PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers
Lee, J., Liow, J., Paul, S., Morse, C. L., Haskali, M. B., Manly, L. S., Shcherbinin, S., Ruble, J. C., Kant, N., Collins, E. C., et al. (2020) · EJNMMI Research · doi:10.1186/s13550-020-0616-4 · Cited by 28
Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease
Li, Y., Tsui, W., Rusinek, H., Butler, T., Mosconi, L., Pirraglia, E., Mozley, D. P., Vallabhajosula, S., Harada, R., Furumoto, S., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.149229 · Cited by 27
99m Tc-3PRGD 2 Scintimammography in Palpable and Nonpalpable Breast Lesions
Liu, L., Song, Y., Gao, S., Ji, T., Zhang, H., Ji, B., Chen, B., Jia, B., Wang, F., Xu, Z., et al. (2014) · Molecular Imaging · doi:10.2310/7290.2014.00010 · Cited by 27
Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain
Yang, K., Stepanov, V., Martinsson, S., Ettrup, A., Takano, A., Knudsen, G. M., Halldin, C., Farde, L., & Finnema, S. J. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx051 · Cited by 27
van Zanten, S. E. M. V., Sewing, A. C. P., van Lingen, A., Hoekstra, O. S., Wesseling, P., Meel, M. H., van Vuurden, D. G., Kaspers, G. J. L., Hulleman, E., & Bugiani, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.197897 · Cited by 27
Jin, H., Yue, X., Liu, H., Han, J., Flores, H. P., Su, Y., Parsons, S. M., Perlmutter, J. S., & Tu, Z. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14291 · Cited by 27
Radiocopper for the imaging of copper metabolism
Hueting, R. (2014) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3155 · Cited by 26
Parker, C. A., Rabiner, E. A., Gunn, R. N., Searle, G. E., Martarello, L., Comley, R. A., Davy, M., Wilson, A. A., Houle, S., Mizrahi, R., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.162743 · Cited by 26
Multi-modality molecular imaging of aortic aneurysms
Malm, B. J., & Sadeghi, M. M. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-0883-2 · Cited by 26
PET imaging of the autonomic nervous system.
Thackeray, J. T., & Bengel, F. M. (2016) · PubMed · Cited by 25
Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors
Cai, Z., Li, S., Pracitto, R., Navarro, A., Shirali, A. R., Ropchan, J. R., & Huang, Y. H. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00268 · Cited by 25
Ebenhan, T., Mokaleng, B. B., Venter, J. D., Kruger, H. G., Zeevaart, J. R., & Sathekge, M. M. (2017) · Molecules · doi:10.3390/molecules22091403 · Cited by 25
Mikulová, M. B., & Mikuš, P. (2021) · Pharmaceuticals · doi:10.3390/ph14020167 · Cited by 25
Pietroboni, A. M., Colombi, A., Carandini, T., Sacchi, L., Fenoglio, C., Marotta, G., Arighi, A., Riz, M. A. D., Fumagalli, G., Castellani, M., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00933-1 · Cited by 25
Xiong, M., Roshanbin, S., Rokka, J., Schlein, E., Ingelsson, M., Sehlin, D., Eriksson, J., & Syvänen, S. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118302 · Cited by 24
Quantitative and Simplified Analysis of 11C-Erlotinib Studies
Yaqub, M. M., Bahce, I., Voorhoeve, C., Schuit, R. C., Windhorst, A. D., Hoekstra, O. S., Boellaard, R., Hendrikse, N. H., Smit, E. F., & Lammertsma, A. A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.165225 · Cited by 24
Hazari, P. P., Pandey, A., Chaturvedi, S., & Mishra, A. K. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00243 · Cited by 24
Makris, G., Kuchuk, M., Gallazzi, F., Jurisson, S. S., Smith, C. J., & Hennkens, H. M. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2019.04.004 · Cited by 24
Increased copper levels in in vitro and in vivo models of Niemann-Pick C disease
Vázquez, M. C., Martínez, P., Alvarez, A. R., González, M., & Zanlungo, S. (2012) · BioMetals · doi:10.1007/s10534-012-9546-6 · Cited by 23
Ito, H., Shinotoh, H., Shimada, H., Miyoshi, M., Yanai, K., Okamura, N., Takano, H., Takahashi, H., Arakawa, R., Kodaka, F., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2620-7 · Cited by 22
Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT
Meester, E. J., Krenning, B. J., de Blois, R. H., Norenberg, J. P., de Jong, M., Bernsen, M. R., & der Heiden, K. V. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-018-1244-5 · Cited by 22
Huang, H.-F., Zhu, H., Li, G., Xie, Q., Yang, X., Xu, X., Tian, X., Wan, Y., & Yang, Z. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00539 · Cited by 22
Cantoni, V., Green, R., Ricciardi, C., Assante, R., Zampella, E., Nappi, C., Gaudieri, V., Mannarino, T., Genova, A., Simini, G. D., et al. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02187-0 · Cited by 22
Mitochondrial-Targeted Molecular Imaging in Cardiac Disease
Li, J., Lu, J., & Zhou, Y. (2017) · BioMed Research International · doi:10.1155/2017/5246853 · Cited by 21
Abiraj, K., Ursillo, S., Tamma, M. L., Rylova, S. N., Waser, B., Constable, E. C., Fani, M., Nicolas, G. P., Reubi, J. C., & Maëcke, H. R. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0428-y · Cited by 21
Blazhenets, G., Frings, L., Ma, Y., Sörensen, A., Eidelberg, D., Wiltfang, J., Meyer, P. T., & Initiative, A. D. N. (2021) · Neurology · doi:10.1212/wnl.0000000000011521 · Cited by 21
[18F]FDG-6-P as a novel in vivo tool for imaging staphylococcal infections
Mills, B., Awais, R. O., Luckett, J., Turton, D., Williams, P. M., Perkins, A. C., & Hill, P. J. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0095-1 · Cited by 20
18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases
Grimmer, T., Shi, K., Diehl‐Schmid, J., Natale, B., Drzezga, A. E., Förster, S., Förstl, H., Schwaiger, M., Yakushev, I. Y., Wester, H., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0203-5 · Cited by 20
A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain
Xiao, H., Choi, S., Zhao, R., Plöessl, K., Alexoff, D., Zhu, L., Zha, Z., & Kung, H. F. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00062 · Cited by 20
Alternative and New Radiopharmaceutical Agents for Lung Cancer
Telo, S., Calderoni, L., Vichi, S., Zagni, F., Castellucci, P., & Fanti, S. (2019) · Current Radiopharmaceuticals · doi:10.2174/1874471013666191223151402 · Cited by 19
Sood, A., Shukla, J., Shree, R., Vatsa, R., Modi, M., & Mittal, B. R. (2020) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003409 · Cited by 19
Chen, M., Zhu, W., Du, J., Chen, Y., Han, B., Zhou, D., Huo, L., & Zhuang, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-01740-2 · Cited by 19
Ni, R. (2021) · Pharmaceuticals · doi:10.3390/ph14111179 · Cited by 18
Daouacher, G., von Below, C., Gestblom, C., Ahlström, H. K., Grzegorek, R., Wassberg, C., Sørensen, J., & Waldén, M. (2015) · British Journal of Urology · doi:10.1111/bju.13202 · Cited by 17
Nuclear Medicine Imaging of Neuroendocrine Tumors
Brabander, T., Kwekkeboom, D. J., Feelders, R. A., Brouwers, A. H., & Teunissen, J. J. M. (2015) · Frontiers of hormone research · doi:10.1159/000382059 · Cited by 17
Fukuta, T., Asai, T., Ishii, T., Koide, H., Kiyokawa, C., Hashimoto, M., Kikuchi, T., Shimizu, K., Harada, N., Tsukada, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30127 · Cited by 17
Kawamura, K., Shimoda, Y., Yui, J., Zhang, Y., Yamasaki, T., Wakizaka, H., Hatori, A., Xie, L., Kumata, K., Fujinaga, M., et al. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.10.005 · Cited by 17
Current and novel radiopharmaceuticals for imaging cardiovascular inflammation
Heo, G. S., Sultan, D. H., & Liu, Y. (2020) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.20.03230-6 · Cited by 17
Mou, T., & Zhang, X. (2017) · Molecules · doi:10.3390/molecules22040562 · Cited by 16
64Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor–Expressing Tumors
Pyo, A., Yun, M., Kim, H. S., Kim, T., Lee, J., Kim, J. Y., Lee, S., Kwon, S. Y., Bom, H., Kim, H., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.197020 · Cited by 16
Cook, G., Azad, G. K., Taylor, B. P., Lee, E., Morrison, M. S., Hughes, S., Morris, S. L., Rudman, S. M., Chowdhury, S., & Goh, V. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3926-7 · Cited by 15
Amsallem, M., Saito, T., Tada, Y., Dash, R., & McConnell, M. V. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0224 · Cited by 14
Duvall, W. L., Case, J. A., Lundbye, J., & Cerqueira, M. D. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02093-5 · Cited by 14
A Critical Review of PET Tracers Used for Brain Tumor Imaging
Borja, A. J., Hancin, E. C., Raynor, W., Ayubcha, C., Detchou, D. K. E. D., Werner, T. J., Revheim, M.-E. R., & Alavi, A. A. (2021) · PET Clinics · doi:10.1016/j.cpet.2020.12.004 · Cited by 14
Donnelly, D. J., Preshlock, S., Kaur, T., Tran, T., Wilson, T. C., Mhanna, K., Henderson, B. D., Batalla, D., Scott, P. J. H., & Shao, X. (2022) · Frontiers in Nuclear Medicine · doi:10.3389/fnume.2021.820235 · Cited by 14
Comparison of imaging using 11 C-ITMM and 18 F-FDG for the detection of cerebellar ataxia
Ishibashi, K., Miura, Y., Toyohara, J., Ishii, K., & Ishiwata, K. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.036 · Cited by 13
Yoshii, Y., Yoshimoto, M., Matsumoto, H., Furukawa, T., Zhang, M.-R., Inubushi, M., Tsuji, A. B., Fujibayashi, Y., Higashi, T., & Saga, T. (2017) · Oncotarget · doi:10.18632/oncotarget.21323 · Cited by 13
Fani, M., Weingaertner, V., Peitl, P. K., Mansi, R., Gaonkar, R. H., Garnuszek, P., Mikołajczak, R., Novak, D., Simončič, U., Hubalewska–Dydejczyk, A., et al. (2020) · Pharmaceuticals · doi:10.3390/ph14010019 · Cited by 13
Cited by
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“…delivery Radiopharmaceutical labeling for tracking gene delivery ‑ Nucleic acid delivery for gene therapy ‑ Targeted gene editing and modulation [73] Personalized medicine Radiotracer‑guided customization of drug delivery ‑ Tailored drug delivery based on patient‑specific Customized treatment…”
BackgroundStrobel, J., Müller, H.-P., Ludolph, A. C., Beer, A. J., Sollmann, N., & Kassubek, J. (2023) · Cells · doi:10.3390/cells12242776 · Cited by 10
Metadata
- Authors
- Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-04-30
- Volume
- 23
- Issue
- 9
- Pages
- 5023
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4225247599
- Cited by
- 337
- References
- 413
- FWCI
- 34.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.